PAVM

PAVmed (PAVM)

PAVmed Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PAVM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/13	20:58	PR Newswire (US)	PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute	NASDAQ:PAVM	PAVmed Inc
2024/06/12	21:05	PR Newswire (US)	4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing	NASDAQ:PAVM	PAVmed Inc
2024/05/14	09:43	PR Newswire (US)	PAVmed Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
2024/05/13	21:00	PR Newswire (US)	Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
2024/05/09	20:49	PR Newswire (US)	Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall	NASDAQ:PAVM	PAVmed Inc
2024/05/07	20:39	PR Newswire (US)	Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors	NASDAQ:PAVM	PAVmed Inc
2024/05/03	21:35	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024	NASDAQ:PAVM	PAVmed Inc
2024/05/02	21:35	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024	NASDAQ:PAVM	PAVmed Inc
2024/05/02	20:49	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing	NASDAQ:PAVM	PAVmed Inc
2024/04/30	20:35	PR Newswire (US)	PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute	NASDAQ:PAVM	PAVmed Inc
2024/04/29	21:47	PR Newswire (US)	Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month	NASDAQ:PAVM	PAVmed Inc
2024/04/08	21:30	PR Newswire (US)	Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PAVM	PAVmed Inc
2024/03/27	08:32	PR Newswire (US)	PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PAVM	PAVmed Inc
2024/03/21	22:30	PR Newswire (US)	Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population	NASDAQ:PAVM	PAVmed Inc
2024/03/21	21:30	PR Newswire (US)	PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX	NASDAQ:PAVM	PAVmed Inc
2024/03/20	21:30	PR Newswire (US)	Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference	NASDAQ:PAVM	PAVmed Inc
2024/03/13	21:30	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024	NASDAQ:PAVM	PAVmed Inc
2024/03/12	21:30	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024	NASDAQ:PAVM	PAVmed Inc
2024/03/09	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PAVM	PAVmed Inc
2024/02/24	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PAVM	PAVmed Inc
2024/02/24	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PAVM	PAVmed Inc
2024/02/24	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PAVM	PAVmed Inc
2024/02/24	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PAVM	PAVmed Inc
2024/02/21	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PAVM	PAVmed Inc
2024/02/21	06:45	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PAVM	PAVmed Inc
2024/02/17	07:00	PR Newswire (US)	Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	NASDAQ:PAVM	PAVmed Inc
2024/02/15	21:45	PR Newswire (US)	Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony	NASDAQ:PAVM	PAVmed Inc
2024/02/15	05:38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PAVM	PAVmed Inc
2024/02/10	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PAVM	PAVmed Inc
2024/02/08	21:45	PR Newswire (US)	Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	NASDAQ:PAVM	PAVmed Inc